Genetic study reveals new drug target to cure most common type of liver cancer
A new study analyzing the genetics of HCC tumours published in the journal PLOS Genetics by Augusto Villanueva suggests that drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC) which is the most common type of primary liver cancer.
Jun 25, 2021, 09:18 AM IST